This is archived HHS content.
Skip to main content
HHS
.gov
Search
U.S. Department of Health & Human Services
Search
Close
A-Z Index
About HHS
Programs & Services
Grants & Contracts
Laws & Regulations
Home
>
Blog
> Tags > Medicare
Text Resize
A
A
A
Print
Share
Categories
Coronavirus (9)
Drug Pricing (12)
Emergency Preparedness and Response (11)
Fraud (2)
Global Health (11)
Grants and Contracts (4)
Health Data (2)
Health Insurance Reform (4)
Health IT (6)
HHS Administrative (29)
Holidays and Observances (19)
Medicare and Medicaid (1)
Mental Health and Substance Abuse (9)
Opioids (17)
Prevention and Wellness (42)
Programs for Families and Children (30)
Public Health and Safety (37)
Research (20)
Telehealth (1)
Value-Based Care (2)
Tag: Medicare
How the IPI Model Would Introduce New Market Competition to Medicare Drug Spending
December 6, 2018
By:
John O’Brien
, Senior Advisor to the Secretary for Drug Pricing Reform
Posted In:
Drug Pricing
Tagged:
Medicare
|
Part B
|
prescription drugs
Proposed Changes to Lower Drug Prices in Medicare Advantage and Part D
November 26, 2018
By:
Alex M. Azar II
, Secretary of the Department of Health and Human Services and
Seema Verma
, Administrator of the Centers for Medicare & Medicaid Services
Posted In:
Drug Pricing
Tagged:
Medicare
|
prescription drugs
|
Part D
|
beneficiaries
Answering Your Questions about the IPI Drug Pricing Model
October 30, 2018
By:
Dan Best
, Senior Advisor to the Secretary for Drug Pricing Reform
Posted In:
Drug Pricing
Tagged:
Medicare
|
prescription drugs
Sign Up For Blog Updates
Enter your email:
Subscribe to RSS
Receive latest updates
Back to
T
op
This is archived HHS content.